Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Expensive Performer
1446.7500
-6.25
(
-0.43
%)
NSE
Mar 25, 2025
15:31 PM
37.52% Gain from 52W Low
Volume:
227.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
12 Aug 2023
1446.75
-0.43%
Domestic formulation drives earnings
Neutral:
Ipca Laboratories Ltd.
by
Motilal Oswal
Target: 840
Target
Motilal Oswal
Ipca Laboratories Ltd. is trading
below its 100 day SMA
of 1512.0
More from Ipca Laboratories Ltd.
Recommended
Five stocks to buy from analysts this week - March 25, 2025
The Baseline |
25 Mar 2025, 05:23PM
Market closes flat, JSW Steel's board approves Rs 1,677 crore buyback at Rs 75 per share
Trendlyne Marketwatch |
25 Mar 2025, 04:11PM
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021